Illumina(us:ILMN)
78.39
-1.20%
Updated on 2025-04-02
Open:79.50
Close:78.39
High:80.26
Low:77.74
Prev Close:79.34
Volume:1.87M
Turnover:146.98M
Turnover Ratio:1.18%
Shares:158.40M
MarketCap:12.42B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 858 | 140035427 | 87.91% | 101 | 267 | 382 |
| 2024-03-31 | 859 | 141956859 | 89.28% | 96 | 310 | 348 |
| 2023-12-31 | 908 | 141754156 | 89.27% | 128 | 257 | 434 |
| 2023-09-30 | 921 | 142451198 | 89.99% | 77 | 240 | 483 |
| 2023-06-30 | 979 | 144825058 | 91.60% | 77 | 322 | 434 |
| 2023-03-31 | 995 | 139414758 | 88.24% | 114 | 358 | 392 |
| 2022-12-31 | 984 | 140854279 | 89.54% | 131 | 314 | 417 |
| 2022-09-30 | 962 | 138478764 | 88.03% | 90 | 340 | 415 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Blackrock Inc. | 18073701 | 11.35% | 4262641 | 30.86% |
| 2024-06-30 | Vanguard Group Inc | 15883158 | 9.97% | -2361883 | -12.95% |
| 2024-06-30 | Baillie Gifford & Co | 5605175 | 3.52% | -131243 | -2.29% |
| 2024-06-30 | State Street Corp | 5597144 | 3.51% | -1215147 | -17.84% |
| 2024-06-30 | Loomis Sayles & Co L P | 4461994 | 2.80% | 49717 | 1.13% |
| 2024-06-30 | Capital World Investors | 3381841 | 2.12% | 628337 | 22.82% |
| 2024-06-30 | Wcm Investment Management, Llc | 3352887 | 2.10% | -24334 | -0.72% |
| 2024-06-30 | Bank Of New York Mellon Corp | 3039538 | 1.91% | 204043 | 7.20% |
| 2024-06-30 | Geode Capital Management, Llc | 2679809 | 1.68% | -1069236 | -28.52% |
| 2024-06-30 | Alliancebernstein L.P. | 2491715 | 1.56% | -166915 | -6.28% |
About
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Address:5200 Illumina Way
Website:http://www.illumina.com
Market Movers